CD8A and ovarian cancer: In ovarian cancer patients, LAG-3 and PD-1 co-expression is associated with the dysfunction or depletion of CD8+ T-cells, suggesting that co-inhibition of these two receptors can help revive these cells from the exhausted state (280).